返回 Agenda
Day 2 : Session 5 - Compliance Management
Session Chair(s)
Mangesh Kulkarni, MD
Global Head – Drug Safety
Tata Consultancy Services, India
Speaker(s)
Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness
Seema Jaitly, DrMed
Sagittal Pharma Consulting Ltd, United Kingdom
Managing Director
Sesson 5.2: A risk based approach to real time compliance
Savitha Hanuman, MPHARM
Accenture, India
VP. Accenture Life Sciences Operations
Session 5.3 : Indian Pharmacovigilance - Where do we stand today
J Vijay Venkatraman, MD, MBA
Oviya Medsafe Pvt Ltd, India
Managing Director and CEO